1. G.d. Searle & Company (97 from 1,323 patents)

2. G.d. Searle LLC (11 from 32 patents)

3. Monsanto Company (10 from 3,287 patents)

4. Pharmacia Corporation (9 from 200 patents)

5. Other (6 from 831,952 patents)

6. Monsanto Company of St. Louis (1 from 2 patents)

7. Mosanto Company (1 from 2 patents)

8. G. D. Dearle & Co. (1 from 1 patent)

1. RE43802 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

2. RE43596 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

3. RE42889 - α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

4. 7829564 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

5. 7531538 - α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

6. 7339078 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

7. 7320983 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

8. 7312333 - Retroviral protease inhibitors

9. 7232817 - α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors

10. 7211597 - Substituted pyrazolyl compounds for the treatment of inflammation

11. 7202258 - α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors

12. 7199158 - Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors

13. 7189864 - Method of preparing intermediates useful in synthesis of retroviral protease inhibitors

14. 7186743 - Substituted pyrazolyl compounds for the treatment of inflammation

15. 7161033 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors